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Abstract
Background: In this study, we have examined the role of heterogeneous nuclear
ribonucleoprotein A1 (hnRNP A1) in viral gene expression in T lymphocytes transformed by
HTLV-1.
Results: We have previously observed that hnRNP A1 (A1) down-modulates the post
transcriptional activity of Rex protein of HTLV-1. Here, we tested whether the ectopic expression
of a dominant negative mutant (NLS-A1-HA) defective in shuttling activity or knockdown of the
hnRNPA1 gene using RNA interference could inhibit Rex-mediated export of viral mRNAs in HTLV-
1 producing C91PL T-cells. We show that the expression of NLS-A1-HA does not modify the
export of Rex-dependent viral mRNAs. Conversely, inhibiting A1 expression in C91PL cells by
RNA interference provoked an increase in the Rex-dependent export of unspliced and singly
spliced mRNAs. Surprisingly, we also observed a significant increase in proviral transcription and
an accumulation of unspliced mRNAs, suggesting that the splicing process was affected. Finally, A1
knockdown in C91PL cells increased viral production by these cells. Thus, hnRNP A1 is implicated
in the modulation of the level of HTLV-1 gene expression in T cells transformed by this human
retrovirus.
Conclusions: These observations provide an insight into a new cellular control of HTLV-1
replication and suggest that hnRNP A1 is likely part of the regulatory mechanisms of the life cycle
of this human retrovirus in T cells.
Background
The human T cell leukemia/lymphotropic virus type 1 is
the etiologic agent of adult T cell leukemia (ATL), an
aggressive and fatal leukemia of CD4+ T lymphocytes
[1,2] and is also associated with a neurological demyeli-
nating disease, tropical spastic paraparesis (TSP) or HTLV-
I associated myelopathy (HAM)[3]. Infection by HTLV-1
transforms T cells in vitro and in vivo, a process that has
been associated with upregulation of specific cellular
genes involved in T cell activation and proliferation dur-
ing the course of viral infection [4-6]. The completion of
the replication cycle of HTLV-1 leading to the production
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of new particles is dependent on two non-structural
HTLV-1 encoded regulatory proteins, Tax and Rex, which
act at the transcriptional and post-transcriptional levels,
respectively [7,8]. The 40-kDa Tax protein trans-activates
transcription of the provirus, through its interaction with
cellular transcription factors and with Tax response ele-
ments present in the 5' long terminal repeat (LTR). The
post-transcriptional activity of the 27-kDa Rex protein, an
RNA-binding protein, is mediated by its interaction with
the Rex response element (XRE) located on the U3/R
region of the 3'LTR present on all viral transcripts [9].
When expressed at a critical threshold, Rex is able to direct
the cytoplasmic expression of unspliced gag-pol and sin-
gly-spliced env mRNAs, at the expense of the multiply-
spiced tax/rex mRNA [10,11]. We have recently reported
that heterogeneous nuclear ribonucleoprotein A1
(hnRNP A1) interferes with the binding of Rex to the XRE,
thus leading to a functional impairment of this viral pro-
tein [12].
The ubiquitously expressed hnRNP A1 is an abundant
nuclear protein that participates in RNA processing, alter-
native splicing and chromosome maintenance as well as
in the nucleocytoplasmic transport of mRNAs [13-18].
This protein contains two RNA-binding domains and a
glycine-rich domain implicated in protein-protein inter-
actions. Predominantly located in the nucleus, this cellu-
lar protein has the ability to shuttle continuously between
the nucleus and the cytoplasm [19-21]. The signal that
mediates both nuclear import and export has been identi-
fied as a 38-aa sequence, termed M9, located at the C-ter-
minus of hnRNP A1, and is involved in the nucleo-
cytoplasmic trafficking of mRNAs [22].
As indicated above, we have provided evidence that
hnRNP A1 impairs the post-transcriptional regulation of
HTLV-1 gene expression, by interfering with the binding
of Rex to the XRE [12]. In the present study, we first dem-
onstrate that the mutation of a putative binding site of
hnRNP A1 to the XRE leads to an increase of the post-tran-
scriptional activity of Rex. Next, to further address the
effect that hnRNP A1 might exert on viral replication in
vivo, we elected to investigate its implication in HTLV-1
producing T cells. Two experimental approaches were
implemented: impairment of the functional activity of the
endogenous hnRNP A1 by ectopic expression of a domi-
nant negative mutant and knockdown of the hnRNPAl
gene expression using RNA interference (siRNA). We
report that inhibition of hnRNP A1 expression and func-
tionality were achieved, leading to an increase of viral
transcription together with an increase of cytoplasmic
expression of viral mRNAs and of viral production. These
observations by providing insight into a new cellular con-
trol of HTLV-I replication, suggest that hnRNP A1 is likely
part of the regulatory mechanisms of the life cycle of this
human retrovirus.
Results
A putative hnRNP A1 binding site has been identified,
close to the minimal Rex binding site in the stem-loop D
of the XRE (Fig 1A). To further evaluate the role of this
binding site in the impairment of the functional activity of
Rex, two punctual mutations were performed in the CMV/
XRE vector containing the indicator luc gene (Fig 1B).
These mutations modify the UAGGUA sequence into
CCGGUA, and the UACCUA sequence into UACCGG,
respectively, thus generating the CMV/mutXRE vector.
Either vector (CMV/XRE and CMV/mutXRE), or the con-
trol vector (CMV 128, containing only the luc gene) were
then transiently transfected in Jurkat cells in the absence
or in the presence of a Rex-expressing plasmid. It was
observed that, in presence of Rex, luc expression in cells
transfected with the CMV/mutXRE vector was more than
3-fold higher than that in cells transfected with the CMV/
XRE vector (Fig 1C). These results indicate that the puta-
tive hnRNPAl binding site close to the Rex binding site on
the SLD sequence in the XRE is directly or indirectly impli-
cated in down-modulating the post-transcriptional activ-
ity of Rex. Since the mutations affect a putative binding
site for hnRNP A1, these results suggest that hnRNP A1
might be the effector of this down-regulation. To further
delineate how this cellular protein perturbs the life cycle
of HTLV-1, we elected to investigate its implication in
HTLV-1 producing T cells. Two experimental approaches
were implemented: impairment of the endogenous
hnRNP A1 by ectopic expression of a dominant negative
mutant (NLS-A1-HA) defective in shuttling activity and
knockdown of the hnRNP A1 gene using RNA interference
(RNAi).
A nucleus-localized shuttling-deficient hnRNP A1 mutant 
does not affect the post-transcriptional activity of Rex
The NLS-A1-HA construct contains the bipartite-basic
type NLS of hnRNP K fused in frame with the N-terminus
of an HA-tagged hnRNP A1 mutant, which lacked both
nuclear import and export activities and inhibits hnRNP
A1-dependent mRNA export when microinjected into
nuclei of Xenopus laevis oocytes [22,23]. This hnRNP A1
mutant which retains the hnRNP A1 nuclear localization,
lacks nuclear export activity [24]. As such, the nucleus-
localized NLS-A1-HA has the potential to compete with
wild-type hnRNP A1 for binding to mRNAs, and for its
nuclear export. A retroviral vector LXSP-NLS-A1-HA was
used to ectopically express this dominant negative mutant
in the HTLV-1 transformed C91PL T cells. In these cells,
Rex governs the cytoplasmic accumulation of unspliced
(gag/pol) and singly-spliced (env) mRNAs. After a few days
of culture in presence of puromycin, immunostaining of
the resistant population revealed that about 30% of the
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cells were displaying HA labelling (Fig. 2). Dual immu-
nostaining indicated that both endogenous hnRNP A1
(anti-hnRNP A1, red) and ectopically expressed NLS-A1-
HA (anti-HA, green) displayed a nuclear diffuse staining
excluding the nucleoli.
We next investigated whether overexpression of this defec-
tive hnRNP A1 mutant was interfering with the expression
of viral mRNAs. Quantification of the nuclear and the
cytoplasmic levels of unspliced gag/pol, singly spliced env
and doubly spliced tax/rex mRNAs was performed by RQ-
PCR involving pair of primers specific of each viral mRNA
(Fig. 3A). The comparative analysis of the viral mRNAs
expression pattern between the control (LXSP) and NLS-
A1-HA cells revealed a small increase of unspliced gag/pol
and of doubly spliced tax/rex mRNAS in the latter,
whereas no modification was observed for the singly
spliced env mRNAs (Fig. 3B). The ratio of nuclear to total
RNA and that of cytoplasmic to total RNA allowed to cal-
culate a nuclear export rate (NER). Whereas the cytoplas-
mic expression of tax/rex mRNAs was slightly enhanced in
cells expressing the NLS-A1-HA mutant, the NER of the
unspliced and singly spliced mRNAs was not affected (Fig
3C). As the cytoplasmic expression of these mRNAs is Rex
Functional characterization of HTLV-1 mutated XRE sequenceigure 1
Functional characterization of HTLV-1 mutated XRE sequence. (A) Schematic representation of the HTLV-1 XRE. 
On the left, the XRE corresponds to U3 and R sequences within the HTLV-1 long terminal repeat, and consists of four stem-
loops. On the right, the predicted secondary structure of the stem-loopD (SLD) with the minimal Rex binding site and the 
mutations introduced within the putative hnRNP A1 binding site are indicated. (B) Schematic view of the reporter plasmid 
CMV/XRE. (C) Effect of mutations within the XRE sequence on the Rex trans-activation capacity. Jurkat cells were transfected 
with 1 µg of the indicated reporter plasmid in the presence or not of Rex expression plasmid (200 ng) and the constitutive 
internal control tk-renilla luciferase vector (10 ng). Data are expressed as normalized luciferase activity and the error bars rep-
resent the standard deviations from three independent experiments.
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dependent, these results indicate that the ectopic expres-
sion of the NLS-A1-HA mutant in C91 PL cells does not
interfere with the functionality of Rex. However and sur-
prisingly, a more than 4-fold increase of the p19gag
amount in the supernatant medium of NLS-A1-HA-trans-
duced cells (2786 ± 154 pg/ml) was observed, when com-
pared to the respective control cells (678 ± 104 pg/ml).
Taken together, these results indicate that the impairment
of the hnRNP A1 functionality might favour the transla-
tion of cytoplasmic viral mRNAs.
Efficient inhibition of hnRNP A1 by retrovirus-delivered 
siRNAs
We next evaluated whether HTLV-1 replication is modu-
lated by RNA interference with hnRNP A1 gene expres-
sion. To that aim, two oligonucleotides encoding siRNA
directed against hnRNP A1, one targeting an RNA
sequence located on the 5' end (34-nt after the translation
start site), and the other an RNA sequence close to the
3'end (548-nt after translation start site) were each
inserted in the pRS retroviral vector [25], as indicated in
Materials and Methods. Both pRS-siRNA+34 and PRS-
siRNA+548 vectors, as well as the pRS empty vector were
used to produce recombinant retroviral particles used to
transduce Jurkat T cells at a multiplicity of infection
(m.o.i.) of 5. After four days of puromycin selection to
eliminate nontransduced cells, the siRNA mediated-
depletion of hnRNP A1 mRNAs was measured by quanti-
tative RT-PCR. While targeting the 5'end (+34) was found
inefficient, targeting the 3'end (+548) reduced the level of
hnRNP A1 transcripts to 10% of those detected in
untransduced Jurkat cells or in Jurkat cells transduced
Expression of a dominant negative mutant of hnRNP A1 in HTLV-1 producing C91PL cellsFigure 2
Expression of a dominant negative mutant of hnRNP A1 in HTLV-1 producing C91PL cells. Confocal microscopy 
of untransduced (a) or NLS-A1-HA transduced (b)-C91PL cells after dual immunofluorescence staining with anti-HA (green) 
and anti-hnRNP A1 (red) antibodies; the right panels show the overlay of the green and red staining;
B
Fig 4
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with empty (pRS) retroviral particles (Fig. 4A). Impor-
tantly, the siRNA-mediated reduction in A1 levels did not
provoke cell death. Immunoblotting analysis of the PRS-
siRNA +548 cells showed a strong reduction of the hnRNP
A1 protein level, when compared to that in the pRS-
siRNA+34 cells and in control cells (Fig 4B). Furthermore,
the levels of the splicing factor ASF/SF2 were not modified
in these cells. These data indicate that expression of
hnRNP A1 is specifically repressed in the pRS-siRNA+548-
transduced Jurkat cells.
hnRNP A1 depletion in HTLV-1-producing T lymphocytes 
altered the transcriptional profile and increased the post-
transcriptional activity of Rex
The above described retroviral vector system was used to
mediate the in situ synthesis of siRNAs and to suppress
specifically hnRNP A1 gene expression in C91PL cells. Ret-
roviruses produced from pRS-siRNA+548 and from the
pRS empty vector were used to transduce these cells with
a m.o.i. of 5. Four days after transduction, hnRNP A1
depletion was assessed by quantitative PCR analysis of
Effect of ectopic expression of a dominant negative mutant of hnRNP A1 in HTLV-1 producing C91PL cellsFigure 3
Effect of ectopic expression of a dominant negative mutant of hnRNP A1 in HTLV-1 producing C91PL cells. (A) 
Primer location on HTLV-1 mRNA; (B) Analysis of the nucleo-cytoplasmic distribution of viral gene expression in NLS-A1- and 
LXSP- transduced cells. Four days after transduction, mRNAs were extracted from the nuclear and cytoplasmic compartments 
of each cell type and levels of unspliced (gag/pol), singly spliced (env) and doubly spliced (tax/rex) mRNAs were reverse tran-
scribed and quantified by real-time quantitative PCR (RQ-PCR), by using specific primers. Results are expressed as the amount 
of nuclear (grey bar) and cytoplasmic (black bar) indicated mRNA relative to β-actin. (C) Evaluation of the nuclear export rate 
(NER) of Rex-dependent (gag/pol plus env) mRNA and of Rex-independent (tax/rex) mRNA in NLS-A1- or LXSP- transduced 
C91PL cells. Numbers are the ratio between cytoplasmic (C) to total (T) RNA and nuclear (N) to total RNA.
Ratio Rex-dependent mRNA Rex-independent mRNA
LXSP NLS-A1 LXSP NLS-A1
N/T = (Y) 0.75 ± 0.08 1.47 ± 0.10 0.72 ± 0.07 0.69 ± 0.04
C/T = (X) 0.27 ± 0.03 0.51 ± 0.05 0.28 ± 0.03 0.30 ± 0.01
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RNAi-mediated reduction of hnRNP A1 expression in Jurkat cellsFigure 4
RNAi-mediated reduction of hnRNP A1 expression in Jurkat cells. (A) hnRNP A1 mRNA levels in cells transduced 
with the indicated retroviruses were determined by RQ-PCR. Levels in knockdown cells are given as percent mRNA reduction 
relative to the level in control cells transduced with empty pRS virus. Standard deviations are from at least three determina-
tions performed in duplicate. (B) Equal amounts of protein from either nontransduced (lane1) or transduced with the indicated 
virus (lanes 2 to 4) were analyzed by immunoblotting. Actin and ASF/SF2 were used as control. Note that hnRNP A1 was sig-
nificantly depleted in cells transduced with siRNA+548, whereas ASF/SF2 was not affected.
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Analysis of hnRNP A1 depletion in HTLV-1 producing C91PL cellsFigure 5
Analysis of hnRNP A1 depletion in HTLV-1 producing C91PL cells. (A) Analysis of hnRNP A1 mRNA levels in cells 
transduced with the indicated retroviruses. Four days after transduction, cytoplasmic RNA were extracted, reverse tran-
scribed with oligo-dT, and levels of hnRNP A1 mRNA were determined by RQ-PCR. (B) Expression of hnRNP A1, Rex and 
hnRNP C1/C2 was monitored by immunoblotting of total protein extract from C91PL cells transduced with the indicated 
virus. Equivalent protein loading was confirmed by immunoblotting with an anti-actin antibody. (C) Detection of hnRNP A1 and 
p19gag expression in C91PL cells transduced with the indicated virus. Dot plots showing both hnRNP A1 and HTLV-1 gag 
expressions in one representative experiment. The percentage of cells in each quadrant is indicated.
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cytoplasmic mRNAs. In siRNA-transduced C91PL cells,
that transcript represented 32% of that in control pRS
transduced cells (Fig. 5A). Interestingly, a western blot
analysis of cell lysates further showed that hnRNP A1 was
barely detected in siRNA-transduced C91 PL cells, whereas
the levels of Rex, or of hnRNP C1/C2 or of actin were
found unchanged (Fig. 5B). Furthermore, a flow cytome-
try analysis of siRNA-transduced C91PL cells reveals that
hnRNP A1 was detected in 6.1% of these cells, whereas it
was detected in about 70% of the control cells (Fig. 5C).
We next investigated whether the decrease in hnRNP A1
expression in C91PL cells was interfering with the expres-
sion of viral mRNAs. Real-time quantitative PCR assays
were performed to quantify viral mRNAs by using the
same primer pairs described above. Results (from two dif-
ferent transduction experiments) assessing the amount of
total viral mRNAs (Fig 6A) revealed that suppression of
hnRNP A1 in siRNA-transduced C91PL cells was leading
to a significant increase of viral transcription (1.7 to 1.8
fold), when compared to PRS control cells. Then, the anal-
ysis of the relative nuclear and cytoplasmic levels of
unspliced gag/pol, singly spliced env and doubly spliced
tax/rex mRNAs indicated that the expression of unspliced
gag/pol mRNA was 2 and 3-fold enhanced respectively in
the nucleus and cytoplasm of siRNA-transduced C91PL
cells, whereas the expression and the distribution of
spliced env mRNAs were not significantly altered (Fig.
6B). A slight increase of the doubly-spliced tax/rex mRNAs
was observed in both compartments.
These results suggest that inhibition of hnRNP A1 in
C91PL cells mainly correlates with a defect in the splicing
of genomic mRNAs. The NER of the unspliced and singly
spliced mRNAs was significantly higher in siRNA-treated
cells than in control cells, whereas the cytoplasmic
expression of tax/rex mRNAs, which is Rex-independent
was not modified (Fig. 6C). As the nucleo-cytoplasmic
transport of the former is Rex-dependent, these observa-
tions propose that the depletion of hnRNPAl correlates
with an increase of Rex activity. Finally, whereas a flow
cytometry analysis indicated a similar percentage of
p19gag producing cells in siRNA-transduced C91PL cells
and in control cells, the quantification of 19gag in the
supernatant medium of siRNA-transduced cells revealed a
1.5-fold increase of the p19gag amount (1017 ± 26 pg/
ml), compared to that in control cells (678 ± 104 pg/ml).
Collectively, these data support that the hnRNP A1 deple-
tion in HTLV-1-producing T cells increases viral transcrip-
tion, is correlated with a defect in the splicing process at
the level of the gag/pol transcript and increases the post-
transcriptional activity of Rex leading to an increase of
viral production.
Discussion
The ubiquitously expressed hnRNP A1, an RNA-binding
protein, is a nucleocytoplasmic shuttling hnRNP that
accompanies eukaryotic mRNAs from the active site of
transcription to that of translation. As such, hnRNP A1 is
involved in a variety of important cellular functions,
including RNA splicing, transport, turnover and transla-
tion. We have previously shown that hnRNP A1 decreases
the post-transcriptional activity of the Rex protein of
HTLV-1, by interfering with the binding of the viral pro-
tein on its response element, present on the 3' LTR of all
viral RNAs. Here we first report that the mutation of a
putative binding site of hnRNP A1 in the XRE enhances
the functional activity of Rex. This observation obtained
through transient transfection experiments, confirms that
A1 proteins could antagonize the post-transcriptional
activity of Rex, by a competitive mechanism.
We have next investigated the role of hnRNP A1 in HTLV-
1 transformed C91PL cells, which produce HTLV-1 viri-
ons. These express the three differentially spliced (the
unspliced gag/pol, the singly spliced env and the doubly
spliced tax/rex) mRNAs, which encode the structural and
regulatory proteins. The gag/pol and env mRNAs are
dependent on Rex for their cytoplasmic expression. To
determine whether hnRNP A1 interferes with viral replica-
tion, we first examined the effect of the ectopic expression
of an hnRNP A1 mutant (NLS-A1-HA) defective in nuclear
export activity. This mutant was previously used to assess
the potential role of hnRNP A1 in nucleocytoplasmic
shuttling activity in normal and leukemic myelopoiesis.
Interestingly it was found that the ectopic expression of
this dominant negative form of hnRNP A1 resulted in the
downmodulation of the nucleocytoplasmic trafficking of
cellular mRNAs that encode proteins affecting the pheno-
type of normal and transformed myeloid progenitors
[24]. In the present study, we showed that NLS-A1-HA-
C91PL cells expressed a higher level of total viral tran-
scripts than that observed in control cells, suggesting that
the ectopic expression of this hnRNP A1 mutant corre-
lated with an increased proviral transcription and/or sta-
bility of the viral RNA.
Furthermore, no modification of the nuclear export rate
was observed in the NLS-A1-HA-transduced C91PL cells,
indicating that the activity of Rex was not impaired.
Finally, as both endogenous hnRNP A1 and the NLS-A1-
HA mutant, which are nucleus-localized and conse-
quently able to access the XRE did not decrease the Rex-
dependent nucleo-cytoplasmic expression of the viral
mRNAs, we should therefore speculate that the simultane-
ous presence of both types of A1 forbids them to bind the
XRE with maximal efficiency. Interestingly, the increase of
p19gag produced by the NLS-A1-HA C91PL cells suggests
that the retention of the endogenous hnRNP A1 in the
Retrovirology 2005, 2:8 http://www.retrovirology.com/content/2/1/8
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nucleus is favouring an increase in the translation of viral
mRNAs
We have then proceeded to the knockdown of hnRNP A1
gene using the retrovirus-mediated RNA interference. This
system was first validated in transduction experiments
performed in Jurkat T cells. A puromycin-selected popula-
tion of cells was obtained in which a strong overall spe-
cific reduction of hnRNP A1 was observed. Note that this
hnRNP A1-depleted Jurkat cells were not affected in their
growth even for a long time culture (data not shown). This
is consistent with other studies showing that si-RNA-
mediated reduction in A1 levels did not affect cell division
nor provoke cell death in normal cell lines [26].
We next performed siRNA depletion of hnRNP A1 in
C91PL cells and have observed a significant increase in
proviral transcription, as demonstrated by the higher level
of viral transcripts than that in control cells (Figure 6A).
Furthermore, the level of unspliced transcripts was found
to be predominant, compared to the singly-and doubly-
spliced transcripts, in the hnRNP A1 depleted cells, plead-
ing for a splicing default (Fig. 6B). Finally, the increase of
the nuclear export of unspliced and singly spliced mRNAs
Effect of hnRNP A1 depletion on viral gene expressionFigure 6
Effect of hnRNP A1 depletion on viral gene expression. (A) Quantification of total viral gene expression in siRNA-
transduced C91PL cells by quantitative PCR. Nuclear and cytoplasmic mRNAs were extracted from siRNA (black bars)- or 
control PRS (white bars)- transduced C91PL cells. Equal amounts of mRNA were reverse transcribed with oligo-dT and sub-
jected to RQ- PCR. Results are expressed as the relative levels of total viral mRNA to cellular β-actin. Error bars indicate 
standard deviations. (B) Analysis of the nucleo-cytoplasmic expression of viral genes. Four days after transduction, mRNAs 
were extracted and analyzed as in Fig. 3B. Results are expressed as the amount of nuclear (grey bar) and cytoplasmic (black 
bar) indicated mRNA relative to β-actin. (C) Evaluation of the nuclear export rate (NER) of Rex-dependent (gag/pol plus env) 
mRNA and of Rex-independent (tax/rex) mRNA in PRS- or siRNA- transduced C91 PL cells.
Ratio Rex-dependent mRNA Rex-independent mRNA
PRS siRNA PRS siRNA
N/T = (Y) 1.42 ± 0.22 1.28 ± 0.35 0.71 ± 0.03 0.71 ± 0.06
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suggests that the knockdown of hnRNP A1 allows a better
accessibility of Rex to the XRE and leads to the enhance-
ment of the post- transcriptional activity of Rex. This is in
good correlation with the increase in the production of
viral particles, as ascertained by the quantification of the
p19gag protein. Since hnRNP A1 has been implicated in
nuclear export of cellular mature mRNAs [27] as well as
translational and/or posttranslational events of viral
mRNAs (our study), it is possible that its depletion could
affect the expression of several transcription and/or splic-
ing factors, leading to an effect, for instance, on the splic-
ing process of viral mRNAs.
Of the two experimental approaches used in the present
study to apprehend the implication of hnRNP A1 on
HTLV-1 replication in in vitro HTLV-1-transformed T-cells,
that consisting in the depletion of this cellular protein by
RNA interference provides evidence for the role of hnRNP
A1 in restraining the viral life cycle at both transcriptional
and post-transcriptional levels. We conclude from these
findings that down-regulation of hnRNP A1 has an
important role on the replicative potential of HTLV-1 in T
lymphocytes. Consequently, these data allows us to
define hnRNP A1 as a cellular protein endowed with an
anti-HTLV-1 activity.
Methods
pRS construct directing the synthesis of siRNA and 
Plasmids
The vector pRetro-SUPER (pRS) was used to generate bio-
logically active siRNAs from the Pol III H1-RNA gene pro-
moter [25]. Two annealed 64-bp synthetic
oligonucleotides were used: 5'-
gatccccAGCAAGAGATGGCTAGTGCttcaagagaG-
CACTAGCCATCTCTTGCTtttttgga aa-3', and 5'-gatc-
cccCAGCTGAGGAAGCTCTTCAttcaagagaTGAAGAGCTTC
CTCAGCTGtttttgga aa-3'. The sequence of each oligonu-
cleotide was designed (Oligoengine) to encode two 19-nt
(in capital letters) reverse complements homologous to a
portion of hnRNP A1 (nucleotides 34–53 for the first con-
struct, and nucleotides 548–567 for the second one) sep-
arated by a 9-nt spacer region, and ending by Bgl II and
Hind III sites. Each oligonucleotide was then introduced
into pRS resulting in either pRS-siRNA+34 or pRS-
siRNA+548 retroviral vectors, respectively. Plasmids pgag-
pol/MLV and EnvVSV-G were kindly provided by F.L. Cos-
set (U412-Lyon). LXSP-NLS-A1-HA and empty LXSP
retroviral vectors were a kind gift of D. Perrotti and has
been described previously [23,24].
For reporter gene analyses, the luciferase plasmid (CMV/
XRE) was derived from the reporter plasmid pDM138
containing the CAT gene and the XRE sequences [28]. It
expresses, under the control of the cytomegalovirus pro-
moter, a two-exon, one-intron precursor RNA in which
the luc gene and the XRE are located within the intron (see
Fig. 1B). The mutant plasmid (CMV/mutXRE) was gener-
ated using a site-directed mutagenesis kit (Stratagene)
according to the manufacturer's instructions, and with the
following primer, 5'-AAAGCCCTGTCAAAACAGGAAAT-
GGCAAGCGCTTCATCCAGCC-3'. This construct was ver-
ified by DNA sequencing before use in transfection. The
rex-expression plasmid, containing the wild type Rex
sequence under the control of the cytomegalovirus pro-
moter, was a gift from B.C. Cullen.
Cell culture and DNA transfection
Jurkat lymphoblastoid T-cells were incubated at 37°C in a
5% CO2 atmosphere, in RPMI-1640 medium (Invitro-
gen) supplemented with 10% heat-inactivated fetal calf
serum (FCS) and 20 IU/ml penicillin, 20 µg/ml strepto-
mycin. The HTLV-1-transformed T-cell line, C91PL [29]
was cultured in complete RPMI medium. The human epi-
thelial 293T cells and the human rhabdomyosarcoma TE
cellswere cultured in Dulbecco's minimum eagle medium
(DMEM, Invitrogen) supplemented with 10% FCS and 20
IU/ml penicillin, 20 µg/ml streptomycin. These cells
seeded at 1.2 × 105 cells per well of a 12-well plate were
transfected using the calcium phosphate coprecipitation
technique [30]. Jurkat cells were transfected by using the
X-treme GENE Q2 transfection reagent (Roche Molecular
Biochemicals) according to the manufacturer's indica-
tions. The amount of plasmid used in each transfection
assay is indicated in the figure legends. To assess the effi-
ciency of the transfection assay, 10 ng of the tk-renilla
Luciferase plasmid (Promega) were co-transfected in each
assay. Cells were harvested 24 h after transfection, resus-
pended in 100 µl of passive lysis buffer (Promega) and
assayed for both firefly and renilla luciferases by using a
Dual-Luciferase Reporter assay system (Promega).
Preparation of viral stocks and transduction of T cells
Fresh viral stocks were prepared by transfecting 293T cells
(seeded at 5 × 105 cell/well of a 6-well plate) with 2 µg of
pRS or pRS-siRNA together with 1 µg of pgag-pol/MLV
and 0,45 µg of env/VSV-G with ExGen 500 reagent
(Euromedex). Twelve hours later, the cells were washed
once with PBS, and newly produced virions were
harvested over 24 h in 1,5 ml of fresh medium. Viral
supernatants were clarifed by passage through a 0.45-µm
syringe filter and aliquots were stored at -80°C. Titers of
virus stocks were determined by infecting rhabdomyosar-
coma human TE cells (60% confluent) with serially
diluted viral stocks. After infection, cells were split and
plated in the presence of puromycin (5 µg/ml); puromy-
cin-resistant colonies were scored after 7 days. Virus titers
generally ranged from 3 to 5 × 105 transducing units per
ml.
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Transduction of Jurkat or of C91 PL T cells with retroviral
vectors was carried out as followed: briefly, cells (1 × 106)
plated in a 24-well plate were infected at a multiplicity of
infection (moi) of 5 with viral stocks in a final volume of
1.0 ml containing 4 µg of polybrene/ml, for 18 h and
allowed to recover for 24 hr with fresh medium. When
necessary, transduced cells were selected with puromycin
4–5 µg/ml for 4 days and maintained in culture for long
time period with 1 µg/ml puromycin.
RNA isolation and real time quantitative RT-PCR
Nuclear and cytoplasmic RNAs were extracted from 2 ×
106 cells by using an Rneasy RNA-preparation kit (Qia-
gen) according to the manufacturer's instructions. To
reduce the amount of DNA originating from lysis, sam-
ples were treated with Rnase-free Dnase (10 U/µl, Boe-
hringer) for 30 min at 20°C and then for 15 min at 65°C.
500 ng of RNA sample were reverse transcribed by using
oligo(dT)12–18 and Superscript II (Life Technologies,
Inc.). Reverse transcription was performed for 50 min at
42°C. The total cDNA volume of 20 µl was frozen until
real-time quantitative PCR was performed. After thawing
for PCR experiments, the cDNA was diluted in distilled
water and 2 µl of diluted cDNA was used for each PCR
reaction. The realtime quantitative PCR (RQ-PCR) was
performed in special lightcycler capillaries (Roche) with a
lightcycler Instrument (Roche), by using the LightCycler-
FastStart reaction Mix SYBR-Green kit (Roche). The fol-
lowing specific primers were used to detect: hnRNP A1,
sense 5'-AAGCAATTTTGGAGGTGGTG-3' and antisens,
5'-ATAGCCACCTTGGTTTCGTG-3', gag/polHTLV-1sense,
5'-CCCTCCAGTTACGATTTCCA-3' and antisens, 5'-
GGCTTGGGTTTGGATGAGTA-3', envHTLV-1sense, 5'-
CTGTGGTGCCTCCTGAACT-3' and antisens, 5'-AAAGT-
GGCGAGAAACTTACCC-3', pXIII sense, 5'-ATCCCGT-
GGAGACTCCTCAA-3' and antisens, 5'-
CCAAACACGTAGACTGGGTATCC-3'. β-actin sense,5'-
TGAGCTGCGTGTGGCTCC-3' and antisens: 5'-GGCAT-
GGGGGAGGGCATACC-3'.
The thermal cycling conditions consisted of 40 cycles at
95°C for 10 sec, 61°C for 5 sec, 72°C for 10 sec. The flu-
orescence signal increase of SYBR-GREEN was
automatically detected during the 72°C phase of the PCR.
Omission of reverse transcriptase in the RT-PCR protocol
led to a failure of target gene amplification in the positive
controls. Light cycler PCR data were analyzed using Light-
Cycler Data software (Idaho Technology). The software
first normalizes each sample by background subtraction
of initial cycles. A fluorescence threshold is then set at 5%
full scale, and the software determines the cycle number at
which each sample reached this threshold. The fluores-
cence threshold cycle number correlates inversely with the
log of initial template concentration. β-actin transcript
levels were used to normalize the amount of cDNA in
each sample. Melting curve profiles were used to confirm
amplification of specific transcripts.
Immunoblotting
Cells were washed and harvested in ice-cold PBS contain-
ing protease inhibitors (complete mini EDTA-free, Roche
Molecular Biochemicals). Cells were lysed in RIPA buffer
(150 mM NaCI, 50 mM Tris-HCI pH 8.0, 0.5% deoxycho-
late, 0.1% SDS, 0.5% Nonidet P-40, protease inhibitors,
80 U/ml endonuclease) and incubated for 30 min at 4°C.
After centrifugation at 12,000 rpm for 10 min at 4°C, the
supernatant was assayed for protein content by Bradford
assay (Bio-Rad). Equal amounts of proteins were sepa-
rated by SDS/PAGE.
Cells were lysed in Laemmli buffer and equal amounts of
proteins were subjected to 12% SDS-PAGE. They were
subsequently blotted onto nitrocellulose membrane (BA,
Schleicher & Schuell). The membrane was then blocked
overnight at 4°C in blocking buffer (PBS and 0.1%
Tween-20) supplemented 10% non-fat powdered milk
and probed with the appropriate antibody diluted in
blocking buffer plus 10% non-fat powdered milk. The fol-
lowing antibodies were used: rabbit anti-actin (Sigma),
mouse anti-ASF/SF2 (gift from Dr. J. Stevenin) mouse
monoclonal anti-hnRNP A1 and anti-hnRNP C antibod-
ies (4B10 and 4F4, respectively; gifts from G. Dreyfuss),
followed with an anti-rabbit (Immunotech, France) or
anti-mouse (Dako) Immunoglobulin G-horse radish per-
oxidase-conjugated antibody. Blots were then developed
using an enhanced chemiluminescence detection system
(Renaissance, NEN, Life Science Products). Bands were
visualized by using Hyperfilm (Amersham Pharmacia
Biotech).
Flow cytometric analysis and Immunostaining
Cells (5 × 105) were washed twice with PBS, resuspended
in 3% (vol/vol) paraformaldehyde/PBS for 45 min at
room temperature, and permeabilized with 0.5% Triton
X-100/PBS for 5 min. After washing with PBS, the cells
were incubated with specific antibodies (4B10) diluted in
1% BSA/PBS for 1 h. Cells were washed twice with PBS
and were then incubated with FITC-conjugated goat anti-
mouse, PE-conjugated goat anti-rabbit in 1% BSA/PBS for
40 min. Cells were washed three times with PBS and
resuspended in a 2% paraformaldehyde/PBS solution.
The fluorescence intensity was measured on a FACScan
instrument (Becton Dickinson Labware, Mountain View,
Calif;). The integrated fluorescence of the gated popula-
tion was measured, and data from 10,000 analyzed events
were collected.
For immunostaining, C91PL cells were centrifuged on
cytoslides using a cytospin (Thermo Shandon, Pittsburgh,
PA), fixed on slides with 3.7% paraformaldehyde for 15
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min at room temperature, and permeabilized with 0.5%
Triton X100 for 5 min in 4°C. The samples were saturated
with PBS containing 0.5% gelatin and 0.25% bovine
serum albumin for 1 h and stained for 1 h with a 1/100
dilution of a rabbit polyclonal serum directed against HA
(Y11 from Santa Cruz Biotechnology) (NLS-A1-HA stain-
ing) or 1/1000 dilution of mouse monoclonal antibodies
(4B10) (hnRNP A1 staining) in the same saturation solu-
tion. The samples were then washed three times with PBS
containing 0.25% gelatin and incubated for 1 h with a 1/
100 dilution of the following secondary antibodies: goat
anti-rabbit immunoglobulin G conjugated to fluorescein
isothiocyanate (green color for HA) and goat anti-mouse
immunoglobulin G conjugated to lissamine rhodamine
sulfchloride (red color for hnRNP A1) (Jackson Immu-
noresearch). The samples were washed three times in PBS
with 0.25% gelatin and mounted for analysis on a Zeiss
LSM 510 laser scanning confocal microscope.
ELISA
p19gag was measured in culture medium using the RET-
ROTEK HTLV p19 Antigen ELISA kit (Zeptometrix).
Medium of the cell culture was centrifuged at low speed to
remove the cell debris, and filtrated through a 0,45-µm fil-
ter. The amount of Gag protein was quantified in the
resultant supernatant according to the manufacturer pro-
cedure. Results are expressed as pg/ml of p19 protein and
are the mean of two different experiments, each point
tested in quadruplicate.
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